Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.

Fracanzani AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A, Fargion S.

Hepatology. 2001 Mar;33(3):647-51.

PMID:
11230745
2.

Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relatives.

Elmberg M, Hultcrantz R, Ebrahim F, Olsson S, Lindgren S, Lööf L, Stål P, Wallerstedt S, Almer S, Sandberg-Gertzén H, Ekbom A, Askling J.

Gastroenterology. 2009 Oct;137(4):1301-9. doi: 10.1053/j.gastro.2009.07.038. Epub 2009 Jul 18.

PMID:
19622361
3.

Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases.

Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsen EM, Halliday JW, Bassett ML, Powell LW.

J Natl Cancer Inst. 1985 Jul;75(1):81-4.

PMID:
2989605
4.

Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.

Frieden TR, Ozick L, McCord C, Nainan OV, Workman S, Comer G, Lee TP, Byun KS, Patel D, Henning KJ.

Hepatology. 1999 Mar;29(3):883-8.

PMID:
10051493
5.

Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis.

Crawford DH, Fletcher LM, Hubscher SG, Stuart KA, Gane E, Angus PW, Jeffrey GP, McCaughan GW, Kerlin P, Powell LW, Elias EE.

Hepatology. 2004 Jun;39(6):1655-62.

PMID:
15185307
6.

Excess risk of primary liver cancer in patients with diabetes mellitus.

Adami HO, Chow WH, Nyrén O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni JF Jr.

J Natl Cancer Inst. 1996 Oct 16;88(20):1472-7.

PMID:
8841022
7.
8.

Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis.

Fargion S, Fracanzani AL, Piperno A, Braga M, D'Alba R, Ronchi G, Fiorelli G.

Hepatology. 1994 Dec;20(6):1426-31.

PMID:
7982640
9.

Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.

Geier D, Hebert B, Potti A.

Anticancer Res. 2002 Nov-Dec;22(6B):3797-9.

PMID:
12552996
10.

Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.

Kowdley KV, Brandhagen DJ, Gish RG, Bass NM, Weinstein J, Schilsky ML, Fontana RJ, McCashland T, Cotler SJ, Bacon BR, Keeffe EB, Gordon F, Polissar N; National Hemochromatosis Transplant Registry.

Gastroenterology. 2005 Aug;129(2):494-503.

PMID:
16083706
11.

Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.

von Delius S, Lersch C, Schulte-Frohlinde E, Fend F, Dobritz M, Schmid RM, Eckel F.

Z Gastroenterol. 2006 Jan;44(1):39-42.

PMID:
16397838
12.

Long-term survival in patients with hereditary hemochromatosis.

Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G.

Gastroenterology. 1996 Apr;110(4):1107-19.

PMID:
8613000
13.

Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India.

Thakur V, Guptan RC, Hashmi AZ, Sakhuja P, Malhotra V, Sarin SK.

J Gastroenterol Hepatol. 2004 Jan;19(1):86-90.

PMID:
14675248
14.

Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.

Deugnier YM, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouanq J, Jouanolle H, Campion JP, Launois B, Halliday JW, et al.

Gastroenterology. 1993 Jan;104(1):228-34.

PMID:
8419246
15.

Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.

Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O.

Clin Oncol (R Coll Radiol). 2007 Apr;19(3):197-203. Epub 2007 Jan 18.

PMID:
17359907
16.

Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Fattovich G, Stroffolini T, Zagni I, Donato F.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. Review.

PMID:
15508101
17.

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.

Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E; European Concerted Action on Viral Hepatitis (EUROHEP).

Am J Gastroenterol. 2002 Nov;97(11):2886-95.

PMID:
12425564
18.

Outcome of liver transplantation in hereditary hemochromatosis.

Dar FS, Faraj W, Zaman MB, Bartlett A, Bomford A, O'Sullivan A, O'Grady J, Heneghan M, Rela M, Heaton ND.

Transpl Int. 2009 Jul;22(7):717-24. doi: 10.1111/j.1432-2277.2009.00863.x. Epub 2009 Mar 16.

19.

Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.

Ko C, Siddaiah N, Berger J, Gish R, Brandhagen D, Sterling RK, Cotler SJ, Fontana RJ, McCashland TM, Han SH, Gordon FD, Schilsky ML, Kowdley KV.

Liver Int. 2007 Dec;27(10):1394-401. Epub 2007 Oct 9.

20.

Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.

Di Costanzo GG, De Luca M, Tritto G, Lampasi F, Addario L, Lanza AG, Tartaglione MT, Picciotto FP, Ascione A.

Eur J Gastroenterol Hepatol. 2008 Jul;20(7):674-9. doi: 10.1097/MEG.0b013e3282f762e1.

PMID:
18679071

Supplemental Content

Support Center